172 related articles for article (PubMed ID: 6169360)
1. Oncofoetal antigens in cancer of the cervix and ovary.
Cauchi MN; Koh SH; Lim D; Hay DL
Br J Cancer; 1981 Sep; 44(3):403-9. PubMed ID: 6169360
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical localization of carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and human chorionic gonadotropin (HCG) in cervical neoplasia.
Bychkov V; Rothman M; Bardawil WA
Am J Clin Pathol; 1983 Apr; 79(4):414-20. PubMed ID: 6188359
[TBL] [Abstract][Full Text] [Related]
4. Immunologic monitoring of cervical carcinoma.
Almerigogna F; Borri P; Buzzoni P; Locatelli F; Savino L
Eur J Gynaecol Oncol; 1980 Dec; 1(3):164-7. PubMed ID: 6176450
[No Abstract] [Full Text] [Related]
5. An immunohistochemical study of keratin, carcinoembryonic antigen, human chorionic gonadotropin and alpha-fetoprotein in lung cancer.
Kimura N; Ghandur-Mnaymen L
Tohoku J Exp Med; 1985 Jan; 145(1):23-38. PubMed ID: 2580364
[TBL] [Abstract][Full Text] [Related]
6. Tumor markers in the ovarian carcinoma.
Margariti PA; Benedetti Panici P; Villani L; Di Roberto P; Maiorca A; Sacco F; Bompiani A
Eur J Gynaecol Oncol; 1980 May; 1(2):77-9. PubMed ID: 6174341
[No Abstract] [Full Text] [Related]
7. Prognostic significance of oncofetal antigens in patients with ovarian cancer.
Koh SH; Cauchi MN
Aust N Z J Obstet Gynaecol; 1983 May; 23(2):69-72. PubMed ID: 6194783
[TBL] [Abstract][Full Text] [Related]
8. Oncofetal antigens in ovarian cyst fluids.
Kraly DH; Koh SH; Hay DL; Cauchi MN
Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
[TBL] [Abstract][Full Text] [Related]
9. Significance of the presence of tumor associated antigens in the clinical evolution of the ovarian carcinoma: analysis of 13 cases in stage III and IV.
Sacco F; Benedetti Panici P; Margariti PA; Di Roberto P; Maiorca A; Muscatello P; Villani L; Iacobelli S
Eur J Gynaecol Oncol; 1980 Dec; 1(3):136-9. PubMed ID: 6176449
[No Abstract] [Full Text] [Related]
10. Multiple biochemical markers in patients with gynecologic malignancies.
Donaldson ES; van Nagell JR; Pursell S; Gay EC; Meeker WR; Kashmiri R; van deVoorde J
Cancer; 1980 Mar; 45(5):948-53. PubMed ID: 6167342
[TBL] [Abstract][Full Text] [Related]
11. [Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)].
Obata N; Kodama S; Hando T; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):757-66. PubMed ID: 6165791
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
Williams RR; McIntire KR; Waldmann TA; Feinleib M; Go VL; Kannel WB; Dawber TR; Castelli WP; McNamara PM
J Natl Cancer Inst; 1977 Jun; 58(6):1547-51. PubMed ID: 68118
[TBL] [Abstract][Full Text] [Related]
13. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of cellular change to malignancy by tissue localization of blood group antigens, A, B, O(H) and carcino-fetal proteins (CEA, HCG)].
Kodama S
Nihon Gan Chiryo Gakkai Shi; 1983 Dec; 18(8):1987-97. PubMed ID: 6674403
[No Abstract] [Full Text] [Related]
15. Immunohistological study of isoantigens, carcinoembryonic antigen and human chorionic gonadotropin in adenocarcinomas of the uterus.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Inoue Y; Saito J; Nishino T; Kurachi K
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Mar; 36(3):437-42. PubMed ID: 6715926
[TBL] [Abstract][Full Text] [Related]
16. A survey of tumor markers in patients with squamous cell carcinoma of the uterine cervix.
Fritsche HA; Freedman RS; Liu F; Acomb LD; Collinsworth WL
Gynecol Oncol; 1982 Oct; 14(2):230-5. PubMed ID: 6182055
[No Abstract] [Full Text] [Related]
17. CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
Martínez L; Castilla JA; Blanco N; Perán F; Herruzo A
Int J Gynaecol Obstet; 1995 Feb; 48(2):187-92. PubMed ID: 7540567
[TBL] [Abstract][Full Text] [Related]
18. Biological markers in human lung carcinoma: an immunopathological study of six antigens.
Harach HR; Skinner M; Gibbs AR
Thorax; 1983 Dec; 38(12):937-41. PubMed ID: 6198740
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated antigens in gynecologic cancer.
DiSaia PJ
Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
[TBL] [Abstract][Full Text] [Related]
20. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
Tottori K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
